HPV types 6, 11, 16, 18, 26, 31, 33, 35, 39, 44, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 82 (DNA quantitative genotyping, swab/F)
We remind you that independent interpretation of the results is unacceptable, the information provided below is for reference purposes only.
Human papillomavirus (HPV) is a large group of common viruses primarily transmitted through sexual contact, affecting the skin and mucous membranes of the urogenital tract, anogenital region, and oropharynx.
Some HPV types cause benign lesions (such as anogenital warts), while others are classified as high-risk (oncogenic) and are associated with the development of precancerous lesions and malignant tumors.
This test is a molecular (PCR-based) assay designed to detect HPV DNA with simultaneous identification (genotyping) of 21 viral types.
The test includes the following HPV types:
6, 11, 16, 18, 26, 31, 33, 35, 39, 44, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 82.
Among them:
low-risk types - typically associated with benign lesions (e.g., 6, 11, 44)
high-risk types - associated with cancer development (including 16, 18, 31, 33, 45, 52, 58, etc.)
This test is used in both women and men for the diagnosis of HPV infection, assessment of oncogenic risk, and guidance of further clinical management.
Indications
- cervical cancer screening (in combination with cytology)
- abnormal Pap smear results
- cervical lesions (erosion, dysplasia)
- follow-up after treatment of HPV-related conditions
- pregnancy planning
Procedure / Duration
- method: PCR diagnostics (HPV DNA detection)
- specimen: cervical / vaginal swab
- procedure duration: 5–10 minutes
Sources:
https://pubmed.ncbi.nlm.nih.gov/12571259/
https://www.nejm.org/doi/full/10.1056/NEJMoa021641
https://www.mayocliniclabs.com/test-catalog/overview/70464
IMPORTANT!
It is crucial to remember that the information provided in this section is not intended for self-diagnosis or self-treatment. If you experience any discomfort or exacerbation of a medical condition, it is essential to consult a qualified healthcare professional for diagnostic testing and appropriate treatment. Only a qualified specialist can provide an accurate diagnosis and determine the appropriate course of treatment. To ensure the most accurate and consistent evaluation of test results, it is recommended to have them performed at the same laboratory. This is because different laboratories may use varying methods and units of measurement for conducting similar tests.
Preparation:
- avoid testing during menstruation (ideally on days 5–10 of the cycle)
- abstain from sexual activity for 24–48 hours
- do not use vaginal medications (suppositories, creams, gels) for 48 hours
- avoid vaginal douching and intimate hygiene products with antiseptics
- avoid sampling immediately after gynecological examination, colposcopy, or transvaginal ultrasound (minimum 24–48 hours interval)
- postpone testing in case of acute inflammation (as advised by a physician)